Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian Gresham

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Contemporary Clinical Trials Communications|March 6, 2023
The 24-Hour Movement Paradigm: An integrated approach to the measurement and promotion of daily activity in cancer clinical trialsCelina H Shirazipour, Carolina Raines, Marcio A Diniz, et al.
NPJ Digital Medicine|July 16, 2019
Wearable activity monitors to assess performance status and predict clinical outcomes in advanced cancer patientsGillian Gresham, Andrew E Hendifar, Brennan Spiegel, et al.
Contemporary Clinical Trials|November 14, 2017
Wearable activity monitors in oncology trials: Current use of an emerging technologyGillian Gresham, Jennifer Schrack, Louise M Gresham, et al.
Journal of the National Cancer Institute|February 25, 2020
Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity IndexGillian Gresham, Márcio A Diniz, Zahra S Razaee, et al.
NPJ Breast Cancer|November 19, 2022
Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30N Lynn Henry, Sungjin Kim, Ron D Hays, et al.
Pilot and Feasibility Studies|July 21, 2018
Methods to identify and prioritize patient-centered outcomes for use in comparative effectiveness researchEvan Mayo-Wilson, Asieh Golozar, Terrie Cowley, et al.
Journal of Gastrointestinal Oncology|August 29, 2018
Neoadjuvant PET and MRI-based intensity modulated radiotherapy leads to less toxicity and improved pathologic response rates in locally advanced rectal cancerJohn M David, Gillian Gresham, Salma K Jabbour, et al.
JCO Clinical Cancer Informatics|April 4, 2025
Clinician and Patient Perspectives on a Patient-Facing Online Breast Cancer Symptom Visualization ToolGillian Gresham, Michael Luu, N Lynn Henry, et al.
Trials|January 30, 2026
Protocol for a cluster randomized trial to evaluate a faith-based breast cancer screening navigation modelGillian Gresham, Dong Hee Kim, Min Jung Sung, et al.
BMJ Open|June 16, 2023
Benefits of nature-based walking for breast cancer survivorsCelina H Shirazipour, Carolina Raines, Eileen Liu, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Contemporary Clinical Trials Communications|March 6, 2023
The 24-Hour Movement Paradigm: An integrated approach to the measurement and promotion of daily activity in cancer clinical trialsCelina H Shirazipour, Carolina Raines, Marcio A Diniz, et al.
NPJ Digital Medicine|July 16, 2019
Wearable activity monitors to assess performance status and predict clinical outcomes in advanced cancer patientsGillian Gresham, Andrew E Hendifar, Brennan Spiegel, et al.
Contemporary Clinical Trials|November 14, 2017
Wearable activity monitors in oncology trials: Current use of an emerging technologyGillian Gresham, Jennifer Schrack, Louise M Gresham, et al.
Journal of the National Cancer Institute|February 25, 2020
Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity IndexGillian Gresham, Márcio A Diniz, Zahra S Razaee, et al.
NPJ Breast Cancer|November 19, 2022
Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30N Lynn Henry, Sungjin Kim, Ron D Hays, et al.
Pilot and Feasibility Studies|July 21, 2018
Methods to identify and prioritize patient-centered outcomes for use in comparative effectiveness researchEvan Mayo-Wilson, Asieh Golozar, Terrie Cowley, et al.
Journal of Gastrointestinal Oncology|August 29, 2018
Neoadjuvant PET and MRI-based intensity modulated radiotherapy leads to less toxicity and improved pathologic response rates in locally advanced rectal cancerJohn M David, Gillian Gresham, Salma K Jabbour, et al.
JCO Clinical Cancer Informatics|April 4, 2025
Clinician and Patient Perspectives on a Patient-Facing Online Breast Cancer Symptom Visualization ToolGillian Gresham, Michael Luu, N Lynn Henry, et al.
Trials|January 30, 2026
Protocol for a cluster randomized trial to evaluate a faith-based breast cancer screening navigation modelGillian Gresham, Dong Hee Kim, Min Jung Sung, et al.
BMJ Open|June 16, 2023
Benefits of nature-based walking for breast cancer survivorsCelina H Shirazipour, Carolina Raines, Eileen Liu, et al.
Pageof 6